Microtubule-associated proteins (MAPs) of the MAP2/Tau family include the vertebrate proteins MAP2, MAP4, and Tau and homologs in other animals. All three vertebrate members of the family have alternative splice forms; all isoforms share a conserved carboxy-terminal domain containing microtubule-binding repeats, and an amino-terminal projection domain of varying size. MAP2 and Tau are found in neurons, whereas MAP4 is present in many other tissues but is generally absent from neurons. Members of the family are best known for their microtubulestabilizing activity and for proposed roles regulating microtubule networks in the axons and dendrites of neurons. Contrary to this simple, traditional view, accumulating evidence suggests a much broader range of functions, such as binding to filamentous (F) actin, recruitment of signaling proteins, and regulation of microtubule-mediated transport. Tau is also implicated in Alzheimer's disease and other dementias. The ability of MAP2 to interact with both microtubules and F-actin might be critical for neuromorphogenic processes, such as neurite initiation, during which networks of microtubules and F-actin are reorganized in a coordinated manner. Various upstream kinases and interacting proteins have been identified that regulate the microtubulestabilizing activity of MAP2/Tau family proteins. The electronic version of this article is the complete one and can be found online at
Characteristic structural features
All MAP2/Tau family proteins have microtubule-binding repeats near the carboxyl terminus [10] , each containing a conserved KXGS motif that can be phosphorylated ( Figure  2 ) [11, 12] . In addition, each family member contains an amino-terminal projection domain of varying size. In MAP2 and Tau, this domain has a net negative charge and exerts a long-range repulsive force as shown by atomic force microscopy [13] . Each protein has several isoforms, with variation in the length of the projection domain and the number of microtubule-binding repeats [8, 9] . The main forms of MAP2 are MAP2c, which is relatively short, and MAP2a and MAP2b, which have longer projection domains.
MAP2/Tau family members are natively unfolded molecules and, like other proteins in this class, are thought to adopt specific conformations upon binding to their targets (microtubules, F-actin and potentially other molecules) [14] . Most regions of MAP2/Tau proteins seem to be devoid of secondary structure. The only region of MAP2 that appears to form a secondary structure is an amino-terminal domain (residues 86-103), which is found in all isoforms and interacts with the regulatory subunit of protein kinase A (PKA). Like the related domain in the A-kinase anchoring protein AKAP79/150, this region is predicted to form an amphipathic helix [15] .
MAP2 also can interact directly with F-actin [16] ; interestingly, the F-actin-binding site is located within the domain containing the microtubule-binding repeats. Although the MAP2 repeat region is highly similar to that of Tau, neither wild-type Tau nor MAP2 chimeras containing the Tau microtubule-binding repeats can bind to F-actin directly. However, F-actin binding is conferred on Tau if its microtubule-binding domain is exchanged for the corresponding region of MAP2 [16] .
Localization and function

Developmental and regional expression
Mammalian MAP2 is expressed mainly in neurons, but MAP2 immunoreactivity is also detected in some non-neuronal cells such as oligodendrocytes. Its expression is very weak in neuronal precursors and then becomes strong about 1 day after expression of neuron-specific tubulin isoform βIII [17] . MAP2c is the juvenile isoform and is downregulated after the early stages of neuronal development [18] , whereas MAP2b is expressed both during development and adulthood. MAP2a becomes expressed when MAP2c levels are falling and is not detected uniformly in all mature neurons [19] . In the brain, smaller splice forms of Tau (of 50-65 kDa) are differentially expressed during early development. Specifically, Tau isoforms with three microtubule-binding repeats are predominantly expressed during early development, whereas isoforms with four repeats are expressed during adulthood [20, 21] . High-molecular-weight variants of Tau (110-120 kDa) are expressed in peripheral neurons and also at a much lower level in the brain [ MAP2c by itself can induce neurites in Neuro-2a neuroblastoma cells; its microtubule-stabilizing activity is necessary for this effect but is not sufficient, and F-actin dynamics also need to be altered [38]. MAP2's ability to interact with Factin appears to be key to this specific biological function. Unlike MAP2c, neither Tau nor chimeric MAP2c containing the Tau microtubule-binding domain can trigger neurite initiation, an observation that correlates with their lack of Factin binding in vitro [16] . This suggests that MAP2c's ability to interact with both microtubules and F-actin is essential for its neurite-initiation activity.
Knockout experiments in mice suggest that neither MAP2 nor Tau is essential by itself, but each single knockout leads to detectable morphological phenotypes. Tau expression was undetectable after targeted deletion of the first Tau exon, which includes the protein start codon [39] . Homozygous animals showed no major defects in brain morphology, but the microtubule density in small-caliber axons was reduced. Similarly, MAP2 expression was undetectable after deletion of one exon encoding a portion of the MAP2 microtubule-binding domain [40] . Again, homozygous animals showed no major defects in brain morphology, but microtubule density in dendrites was reduced. In addition, dendrite length in cultured neurons was reduced, suggesting a role for MAP2 in supporting dendrite elongation.
The phenotypes of single knockouts suggest specific but nonessential roles for Tau and MAP2 in the morphogenesis of the nervous system. However, these proteins probably have multiple roles in other pathways and can be compensated for by other proteins with redundant functions. Interestingly, the structurally unrelated microtubule-associated protein MAP1B appears to have some redundant roles with both Tau 
Functions of MAP4 and non-neuronal functions of MAP2 and Tau
The widely expressed non-neuronal member of the MAP2/ Tau 
Mechanism and regulation
Microtubules exhibit dynamic instability, an intrinsic behavior characterized by alternating phases of growth, shortening, and pausing. The switch from growth to shortening and the switch from shortening to growth are called catastrophes and rescues, respectively. MAP2/Tau proteins bind along the length of microtubules and stabilize microtubules by altering 
Genome Biology 2004, 6:204 [72] . Many other protein kinases can phosphorylate MAP2/Tau proteins in vitro, but for most the identity of the targeted residues in vivo and the functional consequences of phosphorylation remain to be determined. For example, in the olfactory bulb, a site in the amino-terminal domain of MAP2 is phosphorylated in vivo in a manner that is regulated by sensory-driven neural activity; the function of this phosphorylation is not yet known, however [73] . The regulation of MAPs, including the MAP2/Tau family, has been summarized in a comprehensive review [74] .
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Since their original identification over 20 years ago, classical structural MAPs of the MAP2/Tau family have been extensively characterized in vitro and in vivo. A major challenge for further illuminating their function is the vast number of interaction partners and protein kinases predicted and confirmed to phosphorylate MAP2/Tau proteins. Although some key pathways controlling their activity have been elucidated, a broader and more precise analysis of phosphorylation and other post-translational modifications is needed to fully understand MAP2/Tau protein function in signaling networks controlling the morphogenesis of neurons. Recent progress in understanding the molecular mechanisms underlying MAP-microtubule and MAP-actin interactions in vitro is promising, but biological functions remain elusive. Future studies will need to correlate the effects of MAP2/Tau proteins in vivo with molecular knowledge gained from in vitro analyses. The apparent functional redundancies and cross-talk with other MAPs and cytoskeletal regulators are challenges that will require creative experimental strategies if we are to elucidate the specific functions of MAP2/Tau family proteins in cytoskeletal organization and morphological change.
The FtsZ interaction domain on ZipA is mapped to its carboxyl terminus, a region unrelated to MAP2/Tau, suggesting that ZipA is not a functional homolog of MAP2/Tau proteins. 
